IFNG and neoplasm: Exhausted/dysfunctional CD8+ T cells (13, 14), anti-inflammatory/M2-like tumor-associated macrophages (TAMs) (13, 14), defects in IFNγ signaling (15) or antigen processing and presentation (16) all contribute to resistance.